The stock price is going above to its 52 week low with 476.19% and lagging behind from its 52 week high with -77.08%. The Company Touched its 52-Week High on Sep 18, 2015 and 52-Week Low on Feb 24, 2016. The number of shares now owned by investors are 71.51 mln. The latest trading activity showed that the Mast Therapeutics Inc price went up 8.50% from its 52-week low and trades up 210.00% versus its 52-week high. The stock has received “OVERWEIGHT” rating after consensus analysis from analysts. For the next twelve months, the average of individual price target estimates submitted by covering sell-side analysts is $2.75. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. The firm has a SMA 50 (Simple Moving Average) of $0.73 and a SMA 200-(Simple Moving Average) of $0.51. Threshold Pharmaceuticals, Inc. got Initiated on 5-Sep-14 where investment firm H.C. Wainwright Initiated the stock to Buy.
Advertisement
Threshold Pharmaceuticals Inc.’s (THLD) has YTD performance of 160.42%. Similarly, the company’s last 5 years high P/E ratio is 0.8 and low P/E is 0.8, whereas, the industry’s and sector’s high P/E for the past year is 119.69 and 43.69 respectively and low P/E ratio for the last 5 years is 67.15 for the industry and 20.01 for the Sector. (NASDAQ:AREX) closed the recent trading day at $3.56 with +5.33%. Current price level places the company’s stock about 116.64% from the 52-week high and 567.51% away from the 52-week low.
The company has mean EPS estimate of -0.08 reported by 3 number of analyst for the quarter ending Oct 31, 2016- Nov 4, 2016. It has been assigned a low target price of $15 and a high target price of $23. The price to sales ratio is 17.
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) went up +3.31% during trading on 9/6/2016, hitting $1.48. The number of shares now owned by investors are 15.29 mln. “0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “0” brokerage firms. 0 analysts hold “Sell” rating for the stock. The analyst recommendations from a month ago are 4 Buy, 0 Overweight, 0 Sell, 0 Hold and 0 Underweight. 3 Months Ago, the stock has been rated as “Buy” from 11 Analysts. The count of Hold ratings in that period was 0. The stock had a trading volume of 1.7 M shares. (NASDAQ:CLCD) are 151.11%; 189.2% for the month; 232.82% for the last quarter; 243.87% for the past six-months; and 301.18% for the last 12 months.
Advertisement
The average true range of Threshold Pharmaceuticals Inc.’s (THLD) is recorded at 0.12 and the relative strength index of the stock stands 71.71. The stock is performing 184.71% year to date.
